These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 15158697)

  • 1. A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats.
    Naito Y; Takagi T; Ichikawa H; Tomatsuri N; Kuroda M; Isozaki Y; Katada K; Uchiyama K; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
    Nitric Oxide; 2004 May; 10(3):170-7. PubMed ID: 15158697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats.
    Takagi T; Yoshida N; Isozaki Y; Shimozawa M; Katada K; Manabe H; Hanada O; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Eur J Pharmacol; 2006 Mar; 535(1-3):283-90. PubMed ID: 16545368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats.
    Yoshida N; Takagi T; Isozaki Y; Suzuki T; Ichikawa H; Yoshikawa T
    Mol Med Rep; 2011; 4(1):81-6. PubMed ID: 21461568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
    Naito Y; Katada K; Takagi T; Tsuboi H; Kuroda M; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    World J Gastroenterol; 2006 Apr; 12(13):2024-30. PubMed ID: 16610051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice.
    Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T
    Eur J Pharmacol; 2001 Jan; 412(1):91-9. PubMed ID: 11166740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of small intestinal ischemia-reperfusion injury in rat by anti-cytokine-induced neutrophil chemoattractant monoclonal antibody.
    Yagihashi A; Tsuruma T; Tarumi K; Kameshima T; Yajima T; Yanai Y; Watanabe N; Hirata K
    J Surg Res; 1998 Aug; 78(2):92-6. PubMed ID: 9733624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
    Tomatsuri N; Yoshida N; Takagi T; Katada K; Isozaki Y; Imamoto E; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Jan; 13(1):105-9. PubMed ID: 14654979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats.
    Tsuboi H; Naito Y; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Tsukada M; Yoshikawa T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G678-83. PubMed ID: 17023547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats.
    Naito Y; Takagi T; Uchiyama K; Handa O; Tomatsuri N; Imamoto E; Kokura S; Ichikawa H; Yoshida N; Yoshikawa T
    Redox Rep; 2002; 7(5):294-9. PubMed ID: 12688513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide.
    Katada K; Bihari A; Badhwar A; Yoshida N; Yoshikawa T; Potter RF; Cepinskas G
    J Pharmacol Exp Ther; 2009 Jun; 329(3):919-27. PubMed ID: 19270191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver.
    Takamatsu Y; Shimada K; Yamaguchi K; Kuroki S; Chijiiwa K; Tanaka M
    Dig Dis Sci; 2006 Mar; 51(3):571-9. PubMed ID: 16614969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.
    Ichikawa H; Yoshida N; Takagi T; Tomatsuri N; Katada K; Isozaki Y; Uchiyama K; Naito Y; Okanoue T; Yoshikawa T
    World J Gastroenterol; 2004 Oct; 10(19):2814-7. PubMed ID: 15334676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with mineralocorticoid receptor blocker reduces intestinal injury induced by ischemia and reperfusion: involvement of inhibition of inflammatory response, oxidative stress, nuclear factor κB, and inducible nitric oxide synthase.
    Ozacmak HS; Ozacmak VH; Barut F; Araslı M; Ucan BH
    J Surg Res; 2014 Oct; 191(2):350-61. PubMed ID: 24862878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion.
    Yamaguchi Y; Ohshiro H; Nagao Y; Odawara K; Okabe K; Hidaka H; Ishihara K; Uchino S; Furuhashi T; Yamada S; Mori K; Ogawa M
    J Surg Res; 2000 Dec; 94(2):107-15. PubMed ID: 11104650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neutrophil elastase inhibitor (ONO-5046) on lung injury after intestinal ischemia-reperfusion.
    Takayama M; Ishibashi M; Ishii H; Kuraki T; Nishida T; Yoshida M
    J Appl Physiol (1985); 2001 Oct; 91(4):1800-7. PubMed ID: 11568165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative.
    Naka M; Nanbu T; Kobayashi K; Kamanaka Y; Komeno M; Yanase R; Fukutomi T; Fujimura S; Seo HG; Fujiwara N; Ohuchida S; Suzuki K; Kondo K; Taniguchi N
    Biochem Biophys Res Commun; 2000 Apr; 270(2):663-7. PubMed ID: 10753680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a potent iNOS inhibitor (ONO-1714) on acetaminophen-induced hepatotoxicity in the rat.
    Kamanaka Y; Kawabata A; Matsuya H; Taga C; Sekiguchi F; Kawao N
    Life Sci; 2003 Dec; 74(6):793-802. PubMed ID: 14654171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells.
    Lara-Marquez ML; Mehta V; Michalsky MP; Fleming JB; Besner GE
    Nitric Oxide; 2002 Mar; 6(2):142-52. PubMed ID: 11890738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.